SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2007Is Sanofi obligated to keep/maintain %-tage ownership constant? Not obliged to dDewDiligence_on_SI-1/13/2017
2006I do not know. Math may not add up completely. Sanofi bought ~80K shares, Yan anMiljenko Zuanic-1/13/2017
2005Aren't those purchases simply to maintain SNY's pro rata equity stake asDewDiligence_on_SI-1/13/2017
2004secfilings.nasdaq.com Sanofi is bit active.Miljenko Zuanic-1/13/2017
2003I am not sure they are going after Soliris and PNH (regardless what was on slideMiljenko Zuanic-1/9/2017
2002Look out Soliris. Competition for the paroxysmal nocturnal hemoglobinuria. AndBiotech Jim-1/9/2017
2001FDA accepted SANOFI response to 483 (plan and implication of corrective actions)Miljenko Zuanic-1/9/2017
2000Eylea 4Q sale flat over 3Q ($858M v 854). Holidays factor/effects??? Will see wMiljenko Zuanic-1/9/2017
1999<It boggles my mind that the concept of an Ab to a particular epitope (even iMiljenko Zuanic-1/6/2017
1998It boggles my mind that the concept of an Ab to a particular epitope (even if thFelix B-1/6/2017
1997REGN versus AMGN, bloomberg.com There are two path here: A) make a deal with AMiljenko Zuanic-1/5/2017
1996<Regeneron also has spent more than a year considering whether to build a secMiljenko Zuanic-1/5/2017
1995This note: "One limitation of the study is that it didn’t nail down any newMiljenko Zuanic-12/22/2016
1994My view is: A LOT! I can not put specific numbers, for instance as part of theiMiljenko Zuanic-12/22/2016
1993How much value do you ascribe to RGC? I.e. what would it be worth as a standalonDewDiligence_on_SI-12/22/2016
1992RE:RGC in Science J. investor.regeneron.comMiljenko Zuanic-12/22/2016
1991ALL FUxxx gain from OPHT is gone!Miljenko Zuanic-12/19/2016
1990At least, overhead of CMS (Medicare) Part B is gone (for now, price control presMiljenko Zuanic-12/16/2016
1989RE: MEDI (PFE) Well, they is always way to escape misfortune, just increase priMiljenko Zuanic-12/14/2016
1988SanofiW, Le Trait facility/production EMA-certification (from 2-17-2015): eudraMiljenko Zuanic-12/14/2016
1987Actualy, Geel Belgium facility where Sanofi is investing 300Me is Genzyme faciliMiljenko Zuanic-12/14/2016
1986M.Yee is regular BULLSHITER like any other sell-side/by-side analyst. < FinaMiljenko Zuanic-12/14/2016
1985Influential analyst Michael Yee came out with an RBC report on the 12th with thiBiotech Jim-12/14/2016
1984Unfortunately for OPHT, two P3 Fovista trial demonstrate no benefit adding antiMiljenko Zuanic112/12/2016
1983France authority last inspection of Le Trait, France facility was on 11-7-2014,Miljenko Zuanic-12/8/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News